Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
43.60
+3.02 (7.44%)
Jan 21, 2025, 4:00 PM EST - Market closed
Veracyte Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Veracyte stock have an average target of 39.86, with a low estimate of 28 and a high estimate of 46. The average target predicts a decrease of -8.58% from the current stock price of 43.60.
Analyst Consensus: Buy
* Price targets were last updated on Dec 5, 2024.
Analyst Ratings
The average analyst rating for Veracyte stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $38 → $37 | Strong Buy → Hold | Downgrades | $38 → $37 | -15.14% | Dec 5, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $26 → $28 | Sell | Maintains | $26 → $28 | -35.78% | Nov 18, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $40 → $44 | Buy | Maintains | $40 → $44 | +0.92% | Nov 8, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $34 → $38 | Strong Buy | Maintains | $34 → $38 | -12.84% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Maintains $43 → $46 | Strong Buy | Maintains | $43 → $46 | +5.50% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
452.23M
from 361.05M
Increased by 25.25%
Revenue Next Year
497.40M
from 452.23M
Increased by 9.99%
EPS This Year
0.35
from -1.02
EPS Next Year
0.54
from 0.35
Increased by 54.50%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 469.4M | 525.0M | 587.6M | ||
| Avg | 452.2M | 497.4M | 550.1M | ||
| Low | 427.3M | 465.5M | 518.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.0% | 16.1% | 18.1% | ||
| Avg | 25.3% | 10.0% | 10.6% | ||
| Low | 18.3% | 2.9% | 4.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.41 | 1.00 | 1.19 | ||
| Avg | 0.35 | 0.54 | 0.84 | ||
| Low | 0.23 | 0.08 | 0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 186.4% | 120.5% | ||
| Avg | - | 54.5% | 57.0% | ||
| Low | - | -77.5% | -58.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.